Cargando…
Treatment of conjunctival papilloma with topical interferon alpha-2b - case report
RATIONALE: Conjunctival papilloma is a benign neoplastic lesion of epithelial origin, with a minimal tendency toward malignancy and an exophytic growth type. Etiological factors that contribute to the appearance of papilloma are UV exposure, HPV infection, smoking, and immunodeficiency. A case repor...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035065/ https://www.ncbi.nlm.nih.gov/pubmed/32049852 http://dx.doi.org/10.1097/MD.0000000000019181 |
_version_ | 1783499999788662784 |
---|---|
author | Bolek, Bartłomiej Wylęgała, Adam Teper, Sławomir Kokot, Joanna Wylęgała, Edward |
author_facet | Bolek, Bartłomiej Wylęgała, Adam Teper, Sławomir Kokot, Joanna Wylęgała, Edward |
author_sort | Bolek, Bartłomiej |
collection | PubMed |
description | RATIONALE: Conjunctival papilloma is a benign neoplastic lesion of epithelial origin, with a minimal tendency toward malignancy and an exophytic growth type. Etiological factors that contribute to the appearance of papilloma are UV exposure, HPV infection, smoking, and immunodeficiency. A case report of limbal conjunctival papilloma treatment with topical interferon alpha-2b eye drops applied to the conjunctival sac. PATIENT CONCERNS: A 49-year-old female patient treated in the Clinical Department of Ophthalmology for conjunctival lesion located in the temporal quadrant near the limbus of the right eye. Ocular examination of the patient's eye did not show any abnormalities: visual acuity—20/20, intraocular pressure—16 mmHg. DIAGNOSES: During physical examination, a broad-based pink lesion of size 4 mm × 6 mm was found in interpalpebral bulbar conjunctiva with prominent feeder vessels and soft consistency. Lesion in the biomicroscopic examination did not show any sign of malignancy. In Swept Source Optical Coherence Tomography (SS-OCT) there was no sign of infiltration into sclera or cornea. In vivo confocal microscopy (IVCM) examination, revealed loss of the normal conjunctival epithelium - hyper-reflective cells, variation of cell size. A clinical diagnosis of limbal conjunctival papilloma was made. INTERVENTIONS: Interferon alpha-2b 1 million IU/ml eye drops were applied 4 times a day for 5 months. The treatment lasted 5 months without changing the dosing regimen. Three months after the start of the interferon treatment, a complete regression of the lesion was achieved. Treatment was continued for the following 2 months. Controlled IVCM after 6 months showed only few hyper-reflective cells and fibrotic tissue. OUTCOMES: Treatment of conjunctival papilloma with topical interferon alpha-2b led to the complete regression of the lesion. Although after the therapy the conjunctiva appears normal both in slit lamp and in the OCT examination, there is a noticeable fibrosis of the tissue in confocal microscopy. During the 14-month follow-up period, there were no recurrent lesions. LESSONS: In this study, topical interferon alpha-2b has been shown to be an effective and safe therapy for small-to-medium-size conjunctival papilloma without any sign of malignancy. |
format | Online Article Text |
id | pubmed-7035065 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-70350652020-03-10 Treatment of conjunctival papilloma with topical interferon alpha-2b - case report Bolek, Bartłomiej Wylęgała, Adam Teper, Sławomir Kokot, Joanna Wylęgała, Edward Medicine (Baltimore) 5800 RATIONALE: Conjunctival papilloma is a benign neoplastic lesion of epithelial origin, with a minimal tendency toward malignancy and an exophytic growth type. Etiological factors that contribute to the appearance of papilloma are UV exposure, HPV infection, smoking, and immunodeficiency. A case report of limbal conjunctival papilloma treatment with topical interferon alpha-2b eye drops applied to the conjunctival sac. PATIENT CONCERNS: A 49-year-old female patient treated in the Clinical Department of Ophthalmology for conjunctival lesion located in the temporal quadrant near the limbus of the right eye. Ocular examination of the patient's eye did not show any abnormalities: visual acuity—20/20, intraocular pressure—16 mmHg. DIAGNOSES: During physical examination, a broad-based pink lesion of size 4 mm × 6 mm was found in interpalpebral bulbar conjunctiva with prominent feeder vessels and soft consistency. Lesion in the biomicroscopic examination did not show any sign of malignancy. In Swept Source Optical Coherence Tomography (SS-OCT) there was no sign of infiltration into sclera or cornea. In vivo confocal microscopy (IVCM) examination, revealed loss of the normal conjunctival epithelium - hyper-reflective cells, variation of cell size. A clinical diagnosis of limbal conjunctival papilloma was made. INTERVENTIONS: Interferon alpha-2b 1 million IU/ml eye drops were applied 4 times a day for 5 months. The treatment lasted 5 months without changing the dosing regimen. Three months after the start of the interferon treatment, a complete regression of the lesion was achieved. Treatment was continued for the following 2 months. Controlled IVCM after 6 months showed only few hyper-reflective cells and fibrotic tissue. OUTCOMES: Treatment of conjunctival papilloma with topical interferon alpha-2b led to the complete regression of the lesion. Although after the therapy the conjunctiva appears normal both in slit lamp and in the OCT examination, there is a noticeable fibrosis of the tissue in confocal microscopy. During the 14-month follow-up period, there were no recurrent lesions. LESSONS: In this study, topical interferon alpha-2b has been shown to be an effective and safe therapy for small-to-medium-size conjunctival papilloma without any sign of malignancy. Wolters Kluwer Health 2020-02-14 /pmc/articles/PMC7035065/ /pubmed/32049852 http://dx.doi.org/10.1097/MD.0000000000019181 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 5800 Bolek, Bartłomiej Wylęgała, Adam Teper, Sławomir Kokot, Joanna Wylęgała, Edward Treatment of conjunctival papilloma with topical interferon alpha-2b - case report |
title | Treatment of conjunctival papilloma with topical interferon alpha-2b - case report |
title_full | Treatment of conjunctival papilloma with topical interferon alpha-2b - case report |
title_fullStr | Treatment of conjunctival papilloma with topical interferon alpha-2b - case report |
title_full_unstemmed | Treatment of conjunctival papilloma with topical interferon alpha-2b - case report |
title_short | Treatment of conjunctival papilloma with topical interferon alpha-2b - case report |
title_sort | treatment of conjunctival papilloma with topical interferon alpha-2b - case report |
topic | 5800 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035065/ https://www.ncbi.nlm.nih.gov/pubmed/32049852 http://dx.doi.org/10.1097/MD.0000000000019181 |
work_keys_str_mv | AT bolekbartłomiej treatmentofconjunctivalpapillomawithtopicalinterferonalpha2bcasereport AT wylegałaadam treatmentofconjunctivalpapillomawithtopicalinterferonalpha2bcasereport AT tepersławomir treatmentofconjunctivalpapillomawithtopicalinterferonalpha2bcasereport AT kokotjoanna treatmentofconjunctivalpapillomawithtopicalinterferonalpha2bcasereport AT wylegałaedward treatmentofconjunctivalpapillomawithtopicalinterferonalpha2bcasereport |